Invitrogen Patents – Key Insights and Stats

Invitrogen has a total of 3118 patents globally, out of which 632 have been granted. Of these 3118 patents, only 2% patents of the portfolio are active. Europe is where Invitrogen has filed the maximum number of patents, followed by the USA and Japan. The USA seems to be the main focused R&D center and is also the origin country of Invitrogen.

Invitrogen is the subpart of Thermo Fisher Scientific was founded in the year 1987. Invitrogen Corporation provides essential life science technologies for disease research, drug discovery, and commercial bio-production. The company’s own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery.

Do read about some of the most popular patents of Invitrogen which have been covered by us in this report and also you can find Invitrogen’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Invitrogen’s patent portfolio.

How many patents does Invitrogen have?

Invitrogen has a total of 3118 patents globally. These patents belong to 1147 unique patent families. Out of 3118 patents, 75 patents are active.

How Many Patents did Invitrogen File Every Year?

Invitrogen Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantInvitrogen Applications FiledInvitrogen Patents Granted
20221
202122
202031
201923
201824
201788
201667
201598
2014315
20131012
2012315
2011126

How many Invitrogen patents are Alive/Dead?

Worldwide Patents

Invitrogen Patents Portfolio

How Many Patents did Invitrogen File in Different Countries?

Invitrogen Worldwide Patents

Countries in which Invitrogen Filed Patents

CountryPatents
Europe523
United States Of America358
Japan353
Australia338
Canada267
Austria132
Germany115
China54
New Zealand40
Hong Kong (S.A.R.)28
United Kingdom25
Spain21
Denmark16
India14
Singapore13
Israel9
Brazil8
Korea (South)7
Portugal5
Mexico4
Czech Republic2
Russia2
Italy2
Argentina1
South Africa1
Philippines1
Hungary1
Finland1
Cyprus1
Norway1
Latvia1
Poland1
Slovenia1

Where are Research Centres of Invitrogen Patents Located?

Research Centres of Invitrogen Patents

10 Best Invitrogen Patents

US6649138B2 is the most popular patent in the Invitrogen portfolio. It has received 687 citations so far from companies like Ventana Medical Systems, Fio Corporation, and INSERM.

Below is the list of 10 most cited patents of Invitrogen:

Publication NumberCitation Count
US6649138B2687
US6814934B1413
US6682596B2361
US20040054155A1338
US20040171156A1297
US6500622B2282
US20040014956A1244
US20030119004A1235
US6720140B1226
US6630307B2214

How many inventions of other companies were rejected due to Invitrogen patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Invitrogen invention. They couldn’t because Invitrogen had protected those before them.

Examiners at the USPTO referred 90 Invitrogen patents in 610 rejections (35 USC § 102 or 35 USC § 103 types).

The citing companies in the Invitrogen patent portfolio are Sarepta Therapeutics, Stratos Genomics Inc, and Siemens Healthcare.

List of the Companies whose Patents were rejected citing Invitrogen –

CompanyNumber of Patent Applications that faced Rejection Citing Invitrogen PatentsNumber of Rejections (102 & 103)
Sarepta Therapeutics48
Stratos Genomics Inc47
Siemens Healthcare Diagnostics Ltd315
Src Inc38
Medimmune37
Sysmex Corporation310
Dicerna Pharmaceuticals210
Philips210
Elwha Llc23
Fujifilm22

Count of 102 and 103 Type Rejections based on Invitrogen Patents

Top Invitrogen Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US20100285490A129
US6649138B219
US20070037165A19
US8198084B29
US6500622B28
US20040014956A18
US6630307B27
US20060199196A17
US20100291548A17
US20020004246A17
US20080254482A17
US20020028457A16
US20020155507A16
US7079241B25
US20030099940A15

What Percentage of Invitrogen US Patent Applications were Granted?

Invitrogen (Excluding its subsidiaries) has filed 532 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 249 have been granted leading to a grant rate of 48.4%.

Below are the key stats of Invitrogen patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Invitrogen?

Law FirmTotal ApplicationsSuccess Rate
Life Technologies Corporation41449.88%
Sterne Kessler Goldstein & Fox Pllc3460.00%
Fish & Richardson Pc728.57%
Intellevate Llc714.29%
Kilpatrick Townsend & Stockton Llp616.67%
Leydig Voit & Mayer Ltd616.67%
Foley & Lardner Llp560.00%
Choate Hall & Stewart Llp4100.00%
Leydig Voit & Mayer Ltd475.00%
Morgan & Finnegan Transition Team3100.00%

What are Invitrogen’s key innovation segments?

What Technologies are Covered by Invitrogen?

The chart below distributes patents filed by Invitrogen in different countries on the basis of the technology protected in patents. It also represents the markets where Invitrogen thinks it’s important to protect particular technology inventions.

R&D Focus: How has Invitrogen‘s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Invitrogen?

Updated on December 27, 2022

Was this article helpful?

Leave a Comment